Turkish Journal of Gastroenterology

Association of obesity with chronic kidney disease in elderly patients with nonalcoholic fatty liver disease

Main Article Content

Kexue Luo
Jie Bian
Qinxian Wang
Jiesheng Wang
Fuxing Chen
Hongchun Li
Dong Jin

Abstract


Background/Aims: This study investigated an association between obesity and impaired renal functions in elderly patients with nonalcoholic fatty liver disease (NAFLD) and evaluated the risk factors for chronic kidney disease (CKD) in these patients.<o:p></o:p>

Materials and Methods: A cross-sectional study was performed involving 515 elderly patients (≥ 60 years old) with NAFLD. Demographics, body mass index (BMI), medical history, and laboratory parameters were compared for groups stratified by obesity (≥ 28 kg/m2) or CKD. An association between obesity and CKD was analyzed, and a multivariate logistic regression analysis was conducted for risk factors associated with CKD.<o:p></o:p>

Results: In the overall population, 28.7% were obese and 54.8% had CKD; there were more women (58.8%) than men. The prevalence of hypertension and diabetes was similar between the obese and nonobese groups and between the CKD and non-CKD groups. Obese patients had significantly higher levels of serum uric acid and estimated glomerular filtration rates when compared with the nonobese group. When compared with those without CKD, patients with CKD were significantly older in addition to having higher BMI and serum uric acid levels. The multivariate logistic regression analysis indicated that CKD was positively associated with age, BMI, and serum uric acid levels.<o:p></o:p>

Conclusion: Elderly obese patients with NAFLD are at a higher risk of CKD. NAFLD patients with advanced age, greater BMI, or higher serum uric acid levels are more prone to developing CKD. The renal function of NAFLD patients should be closely monitored.<o:p></o:p>

Cite this article as: Luo K, Bian J, Wang Q, et al. Association of obesity with chronic kidney disease in elderly patients with nonalcoholic fatty liver disease. Turk J Gastroenterol 2019; 30(7): 611-5.<o:p></o:p>

Article Details

Similar Articles

<< < 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 > >> 

You may also start an advanced similarity search for this article.